Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $77.72 ($1,010,357)
  2. 4 Exercise or conversion Chief Scientific Officer acquired 4,137 shares (option exercise)
  3. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $84.65 ($173,533)
  4. 4 Open-market sale Director sold 6,800 shares at $81.97 ($557,396)
  5. 4 Open-market buy Director bought 200 shares at $83.44 ($16,688)
  6. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $82.33 ($164,661)
  7. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.08 ($249,229)
  8. 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $81.09 ($1,054,218)
  9. 4 Exercise or conversion Director acquired 2,200 shares (option exercise)
  10. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $78.63 ($161,192)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $77.65 ($155,305)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $76.04 ($228,128)
  18. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $78.75 ($157,500)
  19. 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $78.75 ($1,023,756)
  20. 4/A Open-market buy 10% owner bought 851,154 shares at $67.00 ($57,027,318)

Page 22 of 38 · 758 filings